Share

PSC- DS COPDefence 21 - An Adaptive Interventional Clinical Investigation to Evaluate the Efficacy and Safety of PulmonYDEFENCE in supporting the prevention of exacerbations in Chronic Obstructive Pulmonary Disease (COPD) patients.

Project objectives

Primary objective

  • To evaluate the performance of PolmonYDEFENCE in reducing the risk of exacerbations.

Secondary objectives 

  • To evaluate the performance of PolmonYDEFENCE in reducing the risk of exacerbations by standard therapy.
  • To evaluate the performance of PolmonYDEFENCE in supporting the prevention of exacerbations.
  • To evaluate the performance of PolmonYDEFENCE in improving the health-related quality of life (HRQoL).
  • To evaluate the safety and tolerability of PulmonYDEFENCE. • To evaluate patient's satisfaction with PulmonYDEFENCE

Start and end date

November 2021 - 2024

Project Manager

Simone Scarlata - Principal Investigator

Coordinating institution of the project

Campus Bio Medico Polyclinic Foundation

Other Institutions involved

  • IRCCS San Raffaele Pisana, Rome

Funding source(s).

• SOFAR SpA
magnifiercrossmenuchevron-downchevron-leftchevron-right